Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Puschmann

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Blood|February 17, 2017
Gain-of-function <i>SAMD9L</i> mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptomsBianca Tesi, Josef Davidsson, Matthias Voss, et al.
Nature Communications|October 27, 2023
The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseasesRuben Smith, Francesca Capotosti, Martin Schain, et al.
Autophagy|December 5, 2022
Substitution of PINK1 Gly411 modulates substrate receptivity and turnoverFabienne C Fiesel, Dominika Fričová, Caleb S Hayes, et al.
European Journal of Neurology|April 28, 2022
Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3Hector Garcia-Moreno, Mercedes Prudencio, Gilbert Thomas-Black, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 2026
Longitudinal Dynamics of Polyglutamine-Expanded ATXN3 in Biofluids of Spinocerebellar Ataxia Type 3Jordan Bartfield, Lukasz Milanowski, Karen R Jansen-West, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 2014
Alpha-synuclein repeat variants and survival in Parkinson's diseaseSun Ju Chung, Joanna M Biernacka, Sebastian M Armasu, et al.
Neurology|November 13, 2015
Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disordersKotaro Ogaki, Shunsuke Koga, Michael G Heckman, et al.
Brain : a Journal of Neurology|November 4, 2016
Heterozygous PINK1 p.G411S increases risk of Parkinson's disease via a dominant-negative mechanismAndreas Puschmann, Fabienne C Fiesel, Thomas R Caulfield, et al.
Brain : a Journal of Neurology|April 6, 2017
Reply: Heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorderAndreas Puschmann, Fabienne C Fiesel, Thomas R Caulfield, et al.
American Journal of Human Genetics|July 19, 2011
VPS35 mutations in Parkinson diseaseCarles Vilariño-Güell, Christian Wider, Owen A Ross, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Blood|February 17, 2017
Gain-of-function <i>SAMD9L</i> mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptomsBianca Tesi, Josef Davidsson, Matthias Voss, et al.
Nature Communications|October 27, 2023
The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseasesRuben Smith, Francesca Capotosti, Martin Schain, et al.
Autophagy|December 5, 2022
Substitution of PINK1 Gly411 modulates substrate receptivity and turnoverFabienne C Fiesel, Dominika Fričová, Caleb S Hayes, et al.
European Journal of Neurology|April 28, 2022
Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3Hector Garcia-Moreno, Mercedes Prudencio, Gilbert Thomas-Black, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 2026
Longitudinal Dynamics of Polyglutamine-Expanded ATXN3 in Biofluids of Spinocerebellar Ataxia Type 3Jordan Bartfield, Lukasz Milanowski, Karen R Jansen-West, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 2014
Alpha-synuclein repeat variants and survival in Parkinson's diseaseSun Ju Chung, Joanna M Biernacka, Sebastian M Armasu, et al.
Neurology|November 13, 2015
Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disordersKotaro Ogaki, Shunsuke Koga, Michael G Heckman, et al.
Brain : a Journal of Neurology|November 4, 2016
Heterozygous PINK1 p.G411S increases risk of Parkinson's disease via a dominant-negative mechanismAndreas Puschmann, Fabienne C Fiesel, Thomas R Caulfield, et al.
Brain : a Journal of Neurology|April 6, 2017
Reply: Heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorderAndreas Puschmann, Fabienne C Fiesel, Thomas R Caulfield, et al.
American Journal of Human Genetics|July 19, 2011
VPS35 mutations in Parkinson diseaseCarles Vilariño-Güell, Christian Wider, Owen A Ross, et al.
Pageof 9